SOD1 and head and neck cancer: One notable example is GC4419 (avasopasem manganese), a SOD mimetic that significantly reduced the severity and duration of oral mucositis in subjects receiving radiotherapy for head and neck cancer in recent phase III clinical trials [355,356].